Bookmark Email Print page

Life sciences

Shaping the evolution of the industry

Life Sciences companies are experiencing a period of unprecedented change. Driven by shifts in age and demographics, disease, the entry of new technologies, increased government regulations, and the pace of health care inflation, life sciences companies will have to dramatically change in order to cope with the future industry environment. The Life Sciences and Health Care global industry practice at Deloitte member firms worldwide can help you address these and other challenges in today's complex life sciences environment. Visit the Health Care page for related information.

transformation amid rising risk Secure supply chain 2015 for life sciences
To succeed and strive beyond 2015, life sciences organizations need to make the supply chain a strategic priority. Learn what to focus on.
Episode-based payment: Perspectives for consideration
This study assists industry stakeholders in understanding the rationale, implementation and impacts of episode-based reimbursement.
transformation amid rising risk Life Sciences: Transformation amid rising risk
As life sciences companies face many challenges, survey results show how the industry is transforming during a period of increased risk.

 

 

 

 

 

 

 

Learn more

  • Life Sciences research
    The latest industry reports.
  • @Regulatory
    Regulatory and legislative developments.
  • The changing face of R&D
    A productivity crisis?
  • Center for Health Solutions
    Public health research and resources.

Related links

  • Follow us on Twitter
    Get our latest health care Tweets.
  • Complimentary subscriptions
    Latest offerings.

Stay connected

  • Contact us
  • Submit RFP
  • RSS feed
  • Global podcasts